Novel OPV2 candidate 1

BIOLOGICAL2 trials

Sponsors

Pierre Van Damme

Conditions

Poliomyelitis

Phase 1

Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults

CompletedNCT03430349

Pierre Van DammePoliomyelitis

Start: 2017-05-16End: 2017-10-27Updated: 2021-02-04

Phase 2

A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

CompletedNCT04544787

Pierre Van DammePoliomyelitis

Start: 2018-10-22End: 2019-05-08Updated: 2021-10-15

Related Papers

Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials.

2025-04-30

Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium.

2022-08-019 citations

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.

2020-12-0944 citations

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.

2019-06-04114 citations